Peter Pitts
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Peter Joe Pitts is currently an Independent Director at Painscript Corp., an Independent Non-Executive Director at Ambio Pharmaceuticals Inc since 2021, an Independent Director at Brainstorm Cell Therapeutics, Inc. starting in 2026, and President of The Center for Medicine in the Public Interest since 2004.
Former positions include Director-Global Regulatory & Health Policy at Porter Novelli, Inc., Independent Director at Ambio Holdings, Inc., and Associate Commissioner-External Relations at the US Food & Drug Administration from 2002 to 2004.
Education includes an undergraduate degree from McGill University, conferred in 1981.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Membre du Conseil | 25/05/2026 |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Provides medical treatment compliance platform services | Directeur/Membre du Conseil | - |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Directeur/Membre du Conseil | 08/10/2020 |
The Center for Medicine in the Public Interest
The Center for Medicine in the Public Interest Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit, nonpartisan research and educational organization for patient-centered health care | President | 01/01/2004 |
| Sociétés | Poste | Fin |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2004 |
Ambio Holdings, Inc.
Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization focused on peptide active pharmaceutical ingredients | Directeur/Membre du Conseil | - |
Porter Novelli, Inc.
Porter Novelli, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Porter Novelli, Inc.
Porter Novelli, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Commercial Services |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Ambio Holdings, Inc.
Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization focused on peptide active pharmaceutical ingredients | Health Technology |
The Center for Medicine in the Public Interest
The Center for Medicine in the Public Interest Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit, nonpartisan research and educational organization for patient-centered health care | Commercial Services |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Provides medical treatment compliance platform services | Technology Services |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national